UHPLC-MS strategies and applications for bioanalyses related to pharmacokinetics and drug metabolism

TrAC - Trends in Analytical Chemistry

Volumn 63, Issue , 2014, Pages 170-179

  Zhao, Longshan ^a   Li, Famei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioanalysis; Drug metabolism; High throughput analysis; Mass spectrometry; MS; Pharmacokinetics; Sample treatment; UHPLC; UHPLC MS; Ultra high performance liquid chromatography

Indexed keywords

DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY;

BIOANALYSIS; DRUG METABOLISMS; HIGH-THROUGHPUT ANALYSIS; MS; SAMPLE TREATMENT; U-HPLC-MS; UHPLC; ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHIES;

PHARMACOKINETICS;

ADEFOVIR; ENTECAVIR; IBUPROFEN; LANSOPRAZOLE;

DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG URINE LEVEL; ELECTROSPRAY; FLOW RATE; HUMAN; MASS SPECTROMETRY; NONHUMAN; REVIEW; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84911920427     PISSN: 01659936     EISSN: 18793142     Source Type: Journal    
DOI: 10.1016/j.trac.2014.08.006     Document Type: Review

References (82)

1. Nováková L. Challenges in the development of bioanalytical liquid chromatography-mass spectrometry method with emphasis on fast analysis. J. Chromatogr. A 2013, 1292:25-37.
2. Holčapek M., Jirásko R., Lísa M. Recent developments in liquid chromatography-mass spectrometry and related techniques. J. Chromatogr. A 2012, 1259:3-15.
3. Guillarme D., Ruta J., Rudaz S., Veuthey J.L. New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches. Anal. Bioanal. Chem 2010, 397:1069-1082.
4. Plumb R., Castro-Perez J., Granger J., Beattie I., Joncour K., Wright A. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom 2004, 18:2331-2337.
5. Castro-Perez J., Plumb R., Granger J.H., Beattie I., Joncour K., Wright A. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom 2005, 19:843-848.
6. Ultra-High Performance Liquid Chromatography and Its Applications 2013, Jonh Wiley & Sons, Inc, Hoboken, New Jersey. Q.A. Xu (Ed.).
7. Guillarme D., Veuthey J.-L. UHPLC in Life Sciences 2012, The Royal Society of Chemistry, Cambride, UK.
8. Chesnut S.M., Salisbury J.J. The role of UHPLC in pharmaceutical development. J. Sep. Sci 2007, 30:1183-1190.
9. Thevis M., Thomas A., Pop V., Schänzer W. Ultrahigh pressure liquid chromatography-(tandem) mass spectrometry in human sports drug testing: possibilities and limitations. J. Chromatogr. A 2013, 1292:38-50.
10. Gosetti F., Mazzucco E., Gennaro M.C., Marengo E. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. J. Chromatogr. B 2013, 927:22-36.
11. O'Mahony J., Clarke L., Whelan M., Kennedy R.O., Lehotay S.J., Danaher M. The use of ultra-high pressure liquid chromatography with tandem mass spectrometric detection in the analysis of agrochemical residues and mycotoxins in food-challenges and applications. J. Chromatogr. A 2013, 1292:83-95.
12. Denoroy L., Zimmer L., Renaud B., Parrot S. Ultra high performance liquid chromatography as a tool for the discovery and the analysis of biomarkers of diseases: a review. J. Chromatogr. B 2013, 927:37-53.
13. Guillarme D., Schappler J., Rudaz S., Veuthey J.L. Coupling ultra-high-pressure liquid chromatography with mass spectrometry. Trends Anal. Chem 2010, 29:15-27.
14. Noetzli M., Ansermot N., Dobrinas M., Eap C.B. Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS-MS. J. Pharm. Biomed. Anal 2012, 64-65:16-25.
15. Churchwell M.I., Twaddle N.C., Meeker L.R., Doerge D.R., Improving L.C. MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES-MS-MS to HPLC-ES-MS-MS. J. Chromatogr. B 2005, 825:134-143.
16. Yu K., Little D., Plumb R., Smith B. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom 2006, 20:544-552.
17. Rodriguez-Aller M., Gurny R., Veuthey J.L., Guillarme D. Coupling ultra high-pressure liquid chromatography with mass spectrometry: constraints and possible applications. J. Chromatogr. A 2013, 1292:2-18.
18. Sun X.H., Li X., Cai S., Qin F., Lu X.M., Li F.M. High performance liquid chromatography-electrospray ionization mass spectrometric determination of isosorbide 5-mononitrate in human plasma. J. Chromatogr. B 2007, 846:323-328.
19. Zhao L.S., Zhao Y.L., Li Q., Chen X.H., Xiao F., He B.S., et al. A fast, sensitive, and high throughput method for the determination of cefuroxime lysine in dog plasma by UPLC-MS-MS. Talanta 2012, 89:84-90.
20. Qin F., Ma Y.Y., Wang Y.Q., Chen L.Y., Wang D., Li F.M. Determination of nimodipine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and pharmacokinetic application. J. Pharm. Biomed. Anal 2008, 46:557-562.
21. Lu S., Jiang K., Qin F., Lu X.M., Li F.M. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. J. Pharm. Biomed. Anal 2009, 49:163-167.
22. Zhang Y., Xiong Z.L., Qin F., Lu S., Liu W., Li F.M. High-performance liquid chromatography-tandem mass spectrometry for the determination of pidotimod in human plasma and its application to a pharmacokinetic study. J. Chromatogr. B 2009, 877:2566-2570.
23. Adaway J.E., Keevil B.G. Therapeutic drug monitoring and LC-MS-MS. J. Chromatogr. B 2012, 883-884:33-49.
24. Li N., Deng Y., Wang D., Qiao Y., Li F.M. Determination of glibenclamide and puerarin in rat plasma by UPLC-MS-MS: application to their pharmacokinetic interaction study. Talanta 2013, 104:109-115.
25. Li F.M., Maguigad J., Pelzer M., Jiang X.Y., Ji Q.C. A novel 'peak parking' strategy for ultra-performance liquid chromatography/tandem mass spectrometric detection for enhanced performance of bioanalytical assays. Rapid Commun. Mass Spectrom 2008, 22:486-494.
26. Berg T., Lundanes E., Christophersen A.S., Strand D.H. Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS-MS. J. Chromatogr. B 2009, 877:421-432.
27. Hsieh Y. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites. J. Sep. Sci 2008, 31:1481-1491.
28. Xiong Z.L., Zhang Y., Qin F., Qin T., Yang S.Y., Li F.M. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study. J. Chromatogr. B 2010, 878:2111-2116.
29. Nováková L., Gottvald T., Vlčková H., Trejtnar F., Mandíková J., Solich P. Highly sensitive fast determination of entecavir in rat urine by means of hydrophilic interaction chromatography-ultra-high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2012, 1259:237-243.
30. Van Damme T., Lachová M., Lynen F., Szucs R., Sandra P. Solid-phase extraction based on hydrophilic interaction liquid chromatography with acetone as eluent for eliminating matrix effects in the analysis of biological fluids by LC-MS. Anal. Bioanal. Chem 2014, 406:401-407.
31. Magiera S., Baranowska I., Kusa J. Development and validation of UHPLC-ESI-MS-MS method for the determination of selected cardiovascular drugs, polyphenols and their metabolites in human urine. Talanta 2012, 89:47-56.
32. Liu Z.G., Jiang M.Y., Lu X.M., Qin F., Song Y., Wen J., et al. Simultaneous determination of pimpinellin, isopimpinellin and phellopterin in rat plasma by a validated UPLC-MS-MS and its application to a pharmacokinetic study after administration of Toddalia asiatica extract. J. Chromgtogr. B 2012, 891-892:102-108.
33. Tan A., Lévesque I.A., Lévesque I.M., Viel F., Boudreau N., Lévesque A. Analyte and internal standard cross signal contributions and their impact on quantitation in LC-MS based bioanalysis. J. Chromatogr. B 2011, 879:1954-1960.
34. Hu L., Ding L., Li X., Zhou N., Zhong S., Wu G., et al. Interference by metabolites and the corresponding troubleshooting during the LC-MS-MS bioanalysis of G004, a bromine-containing hypoglycemic agent. J. Chromatogr. B 2012, 899:8-13.
35. Committee for Medicinal Products for Human Use Guideline on Bioanalytical Method Validation 2001, EMA, London, UK, last accessed 2011.07.21. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
36. U.S Department of Health and Human Services, Food and Drug Administration, Guidance for Industry Bioanalytical method validation (last accessed 2001.05). http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf.
37. CFDA Guidelines for clinical pharmacokinetic study for chemical drugs last accessed 2005.03. http://www.sda.gov.cn/gsz05106/08.pdf.
38. EMA Guideline on validation of bioanalytical methods last accessed 2009.11.19. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/12/WC500018062.pdf.
39. APVMA Guidelines for the validation of analytical methods for active constituent, agricultural and veterinary chemical products, Australian Pesticides and Veterinary Medicines Authority last accessed 2011.04.19. http://www.apvma.gov.au/publications/guidelines/docs/gl_69_anal%20ytical_methods.pdf.
40. Gosetti F., Mazzucco E., Zampieri D., Gennaro M.C. Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. J. Chromatogr. A 2010, 1217:3929-3937.
41. Van Eeckhaut A., Lanckmans K., Sarre S., Smolders I., Michotte Y. Validation of bioanalytical LC-MS-MS assays: evaluation of matrix effects. J. Chromatogr. B 2009, 877:2198-2207.
42. Ma Y.Y., Qin F., Sun X.H., Lu X.M., Li F.M. Determination and pharmacokinetic study of amlodipine in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry. J. Pharm. Biomed. Anal 2007, 43:1540-1545.
43. Qin F., Li N., Qin T., Zhang Y., Li F.M. Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. J. Chromatogr. B 2010, 878:689-694.
44. Song Y., Deng Y., Huang D.X., Wen J., Liu Z.G., Li F.M. LC-MS-MS determination and pharmacokinetic study of four lignan components in rat plasma after oral administration of Acanthopanax sessiliflorus extract. J. Ethnopharmacol 2012, 141:957-963.
45. Chen L.Y., Qin F., Ma Y.Y., Li F.M. Quantitative determination of azithromycin in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry and its application in a pharmacokinetic study. J. Chromatogr. B 2007, 855:255-261.
46. Cai S., Huo T.G., Feng W.Y., Chen L.Y., Qin F., Li F.M. Quantitative determination of mitiglinide in human plasma by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry. J. Chromatogr. B 2008, 868:83-87.
47. Delavenne X., Juthier L., Pons B., Mariat C., Basset T. UPLC MS-MS method for quantification of mycophenolic acid and metabolites in human plasma: application to pharmacokinetic study. Clin. Chim. Acta 2011, 412:59-65.
48. Gikas E., Bazoti F.N., Katsimardou M., Anagnostopoulos D., Papanikolaou K., Inglezos I., et al. Determination of colistin A and colistin B in human plasma by UPLC-ESI high resolution tandem MS: application to a pharmacokinetic study. J. Pharm. Biomed. Anal 2013, 83:228-236.
49. Wang P., Sun J.B., Gao E.Z., Zhao Y.L., Qu W., Yu Z.G. Simultaneous determination of limonin, dictamnine, obacunone and fraxinellone in rat plasma by a validated UHPLC-MS-MS and its application to a pharmacokinetic study after oral administration of Cortex Dictamni extract. J. Chromatogr. B 2013, 928:44-51.
50. Vlčková H., Rabatinová M., Mikšová A., Kolouchová G., Mičuda S., Solich P., et al. Determination of pravastatin and pravastatin lactone in rat plasma and urine using UHPLC-MS-MS and microextraction by packed sorbent. Talanta 2012, 90:22-29.
51. Zhuang X., Zhong Y., Yuan M., Li H. Pre-column derivatization combined withUHPLC-MS-MS for rapid and sensitive quantification of bakuchiol in rat plasma. J. Pharm. Biomed. Anal 2013, 75:18-24.
52. Jacobson G.A., Pirie A., Edwards S., Hughes K.J., Rendle D.I., Davies N.W. Determination of pergolide in horse plasma by UPLC-MS-MS for pharmacokinetic applications. J. Pharm. Biomed. Anal 2014, 94C:54-57.
53. Liu P., Li Z.H., Qian D.W., Li W., Shang E.X., Duan J.A. Simultaneous determination of bioactive components in essential oil of Xiang-Fu-Si-Wu Formula in Beagle dog plasma by UPLC-MS-MS and its application to pharmacokinetics. J. Chromatogr. B 2013, 929:63-69.
54. Feng S., Zhao Q., Jiang J., Hu P. Determination of phenylephrine in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2013, 915-916:28-32.
55. Chambers E.E., Woodcock M.J., Wheaton J.P., Pekol T.M., Diehl D.M. Systematic development of an UPLC-MS-MS method for the determination of tricyclic antidepressants in human urine. J. Pharm. Biomed. Anal 2014, 88:660-665.
56. Guengerich F.P. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol 2001, 14:611-650.
57. Walsh J.S., Miwa G.T. Bioactivation of drugs: risk and drug design. Annu. Rev. Pharmacol. Toxicol 2011, 51:145-167.
58. Jiang S., Yang J., Qian D., Guo J., Shang E.X., Duan J.A., et al. Rapid screening and identification of metabolites of quercitrin produced by the human intestinal bacteria using ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. Arch. Pharm. Res 2014, 37:204-213.
59. Han H., Yang L., Xu Y., Ding Y., Bligh S.W., Zhang T., et al. Identification of metabolites of geniposide in rat urine using ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Rapid Commun. Mass Spectrom 2011, 25:3339-3350.
60. Zhang G., Gong T., Kano Y., Yuan D. Screening for in vitro metabolites of kakkalide and irisolidone in human and rat intestinal bacteria by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J. Chromatogr. B 2014, 947-948:117-124.
61. Petsalo A., Turpeinen M., Pelkonen O., Tolonen A. Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column. J. Chromatogr. A 2008, 1215:107-115.
62. Walles M., Gauvin C., Morin P.E., Panetta R., Ducharme J. Comparison of sub-2-μm particle columns for fast metabolite ID. J. Sep. Sci 2007, 30:1191-1199.
63. E; a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Comm. Mass Spectrom 2006, 20:1989-1994.
64. Crokford D.J., Maher A.D., Ahmadi K.R., Barrett A., Plumb R.S., Wilson I.D., et al. 1H NMR and UPLC-MSE Statistical Heterospectroscopy: Characterization of Drug Metabolites (Xenometabolome) in Epidemiological Studies. Anal. Chem 2008, 80:6835-6844.
65. Liu M.Y., Zhao S.H., Wang Z.Q., Wang Y.F., Liu T., Li S., et al. Identification of metabolites of deoxyschizandrin in rats by UPLC-Q-TOF-MS-MS based on multiple mass defect filter data acquisition and multiple data processing techniques. J. Chromatogr. B 2014, 949-950:115-126.
66. Lee S.H., Yang H.O., Kwon H.C., Jung B.H. Identification of the urinary metabolites of glionitrin A in rats using ultra-performance liquid chromatography combined with quadrupole time-of-flight mass spectrometry. J. Chromatogr. B 2012, 906:33-40.
67. Zhang A.H., Wang P., Sun H., Yan G.L., Han Y., Wang X.J. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program. Mol. Biosyst 2013, 9:2259-2265.
68. Li K.J., Qin F., Jing L., Li F.M., Guo X.J. In vivo and in vitro metabolism of a novel β2-adrenoceptor agonist, trantinterol: metabolites isolation and identification by LC-MS-MS and NMR. Anal. Bioanal. Chem 2013, 405:2619-2634.
69. Plumb R.S., Rainville P.D., Potts W.B., Castro-Perez J.M., Johnson K.A., Wilson I.D. High-temperature ultra-performance liquid chromatography coupled to hybrid quadrupole time-of-flight mass spectrometry applied to ibuprofen metabolites in human urine. Rapid Commun. Mass Spectrom 2007, 21:4079-4085.
70. Qi M., Xiong A., Li P., Yang Q., Yang L., Wang Z. Identification of acteoside and its major metabolites in rat urine by ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem massspectrometry. J. Chromatogr. B 2013, 940:77-85.
71. Lou Y., Zheng J., Wang B., Zhang X., Zhang X., Zeng S. Metabolites characterization of chamaechromone in vivo and in vitro by using ultra-performance liquid chromatography/Xevo G2 quadrupole time-of-flight tandem mass spectrometry. J. Ethnopharmacol 2014, 151:242-252.
72. Regueiro J., Vallverdú-Queralt A., Negreira N., Simal-Gándara J., Lamuela-Raventós R.M. Identification and quantification of grapefruit juice furanocoumarin metabolites in urine: an approach based on ultra performance liquid chromatography coupled to linear ion trap-orbitrap mass spectrometry and solid-phase extraction coupled to ultraperformance liquid chromatography coupled to triple quadrupole-tandem mass spectrometry. J. Agric. Food Chem 2014, 62:2134-2140.
73. Sun X.H., Zhao L.S., Niu L.L., Qin F., Lu X.M., Xiong Z.L., et al. Structure identification and elucidation of mosapride metabolites in human urine, feces and plasma by ultra performance liquid chromatography-tandem mass spectrometry method. Xenobiotica 2014, 44:734-742.
74. Wu J.L., Leung E.L., Zhou H., Liu L., Li N. Metabolite analysis of toosendanin by an ultra-high performance liquid chromatography-quadrupole-time of flight mass spectrometry technique. Molecules 2013, 18:12144-12153.
75. Uutela P., Monto M., Iso-Mustajärvi I., Madetoja M., Yliperttula M., Ketola R.A. Identification of metabolites of fosinopril produced by human and rat liver microsomes with liquid chromatography-mass spectrometry. Eur. J. Pharm. Sci 2014, 53:86-94.
76. Miao W.J., Wang Q., Bo T., Ye M., Qiao X., Yang W.Z., et al. Rapid characterization of chemical constituents and rats metabolites of the traditional Chinese patent medicine Gegen-Qinlian-Wan by UHPLC/DAD/qTOF-MS. J. Pharm. Biomed. Anal 2013, 72:99-108.
77. Ni S., Qian D., Duan J.A., Guo J., Shang E.X., Shu Y., et al. UPLC-QTOF-MS-based screening and identification of the constituents and their metabolites in rat plasma and urine after oral administration of Glechoma longituba extract. J. Chromatogr. B 2010, 878:2741-2750.
78. Jin X., Li S.L., Zhang Z.H., Zhu F.X., Sun E., Wei Y.J., et al. Characterization of metabolites of 20(S)-protopanaxadiol in rats using ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. J. Chromatogr. B 2013, 933:59-66.
79. Guo J.M., Xue C.F., Shang E.X., Duan J.A., Tang Y.P., Qian D.W. Identification of hyperoside metabolites in rat using ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. J. Chromatogr. B 2011, 879:1987-1992.
80. Shan C.X., Li W., Wen H.M., Wang X.Z., Zhu Y.H., Cui X.B. Identification of liguzinediol metabolites in rats by ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. J. Pharm. Biomed. Anal 2012, 62:187-190.
81. Liu Q.F., Shi Y., Guo T., Wang Y., Cong W.J., Zhu J.J. Metabolite discovery of helicidum in rat urine with XCMS based on the data of ultra performance liquid chromatography coupled to time-of-flight mass spectrometry. J. Chromatogr. B 2012, 907:146-153.
82. E identification of urinary metabolites of the emerging sport nutrition supplement methoxyisoflavone in human subjects. J. Pharm. Biomed. Anal 2014, 96:127-134.